Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host gut environment is a complex biological system within the gastrointestinal tract that includes the gut microbiota, the intestinal mucosal barrier, and the enteric immune system (Guinane & Cotter, 2013). It serves vital biological functions such as the fermentation of non-digestible carbohydrates, the synthesis of vitamins, and the regulation of systemic immune homeostasis (Fan & Pedersen, 2021). Dysregulation of this environment, known as dysbiosis, is strongly associated with various pathologies, including inflammatory bowel disease (IBD), obesity, and type 2 diabetes (Lynch & Pedersen, 2016). Although it is not a single molecular target like a receptor or enzyme, the gut environment is the focus of therapeutic interventions such as probiotics, prebiotics, and fecal microbiota transplants (FMT) which aim to restore microbial diversity and metabolic balance (Khoruts & Sadowsky, 2016). Additionally, non-systemic antibiotics like rifaximin are used to modulate the gut environment to treat conditions like irritable bowel syndrome (Pimentel et al., 2011). Understanding the host-microbe interactions within this environment is crucial for the development of next-generation microbiome-based therapies.
Modulation of microbial community composition, restoration of colonization resistance, and regulation of metabolite production such as short-chain fatty acids (SCFAs).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host gut environment.